- What is peripheral blood stem cell transplantation?
- What are stem cells?
- What do stem cells do?
- What is the value of stem cells for transplantation?
- Where do the stem cells come from for transplantation?
- How are the stem cells removed from the blood?
- How is the patient "prepared" for the transplantation?
- How is the transplantation actually done?
What is peripheral blood stem cell transplantation?
Peripheral blood stem cell transplantation is a treatment which involve first harvesting specific cells called stem cells from the peripheral blood of the donor. These cells are harvested by a type of filtration and then preserved, usually by freezing, and finally given to the recipient after he or she has received intensive treatment. The stem cells are usually given instead of bone marrow cells. They go to the recipient's bone marrow spaces and rebuild the bone marrow after the intensive treatment is over. The treatment does not involve surgery, but is nevertheless a form of transplantation.
What are stem cells?
Stem cells are small, round cells with a squat nucleus and scant surrounding cytoplasm. Although unremarkable in appearance, stem cells can perform what have been called "acts of biological resurrection."
What do stem cells do?
Whereas other types of cells in the body have a limited lifespan and die after dividing their predetermined number of times, a stem cell can reproduce forever. The stem cell is immortal (in cellular terms). A stem cell can forgo immortality and differentiate. By doing so, it can turn into an ordinary blood cell, like a red blood cell (an erythrocyte), a white blood cell (a leukocyte), or a large cell (a megakaryocyte) that fragments into the platelets needed for blood to clot.
What is the value of stem cells for transplantation?
A relatively small number of stem cells can miraculously repopulate the whole bone marrow, provide an endless supply of stem cells, reconstitute the entire repertoire of blood cells, and restore that portion of the immune system.
Where do the stem cells come from for transplantation?
Under normal circumstances, stem cells are rarely seen in the blood stream. To recruit enough stem cells into the blood, stem cells are lured out of the bone marrow by a special regimen of drugs and thereby coaxed into entering the peripheral blood (the blood stream).
How are the stem cells removed from the blood?
The blood is filtered through a machine and the stem cells are skimmed off. The removal of the cells is termed pheresis or apheresis (from the Greek "aphairesis" for removal). The stem cells then may be used right away for the transplant or stored suspended in DMSO and frozen in liquid nitrogen until needed.
How is the patient "prepared" for the transplantation?
Before the transplant is done, the patient receives high-dose chemotherapy and/or radiation therapy over several days to destroy diseased cells (the leukemic cells, lymphoma cells, solid tumor cells, the diseased immune system cells in scleroderma, etc.)
How is the transplantation actually done?
Once the chemotherapy is gone, the stem cells are defrosted and returned to the patient as a blood transfusion. They are already biologically programmed to migrate to the bone marrow, where they can produce new blood and immune cells and replace the cells destroyed by the treatment.
The stem-cell preparation is infused into a vein and, once there in the blood stream, the stem cells act like homing pigeons and head straight for the bone marrow space.
QUESTION
See AnswerREFERENCE:
"Blood-Forming Stem Cell Transplantats." Cancer.gov. Updated Aug. 12, 2013.
Top Peripheral Blood Stem Cell Transplant Related Articles
Bone Cancer
Bone cancer is a rare type of cancer that occurs in cells that make up the bones. Primary bone cancer that arises in bone cells is different than metastatic bone cancer, which is cancer that arises in another part of the body and then spreads to the bones. Hereditary and environmental factors likely contribute to the risk of bone cancer. Signs and symptoms of bone cancer may include pain, the presence of a mass or lump, and bone fractures. There are different types of bone cancer (osteosarcoma, chondrosarcoma, Ewing's sarcoma, pleomorphic sarcoma, fibrosarcoma). Treatment for bone cancer may include surgical removal of the tumor, chemotherapy, radiation, and/or a stem cell transplant. The prognosis for bone cancer depends on the type of cancer and the extent of spread.What are the Risks or Complications of a Bone Marrow Procedure?
A bone marrow biopsy involves using a large needle to extract a sample from the bone marrow to diagnose blood cancers and other conditions. Bone marrow is often extracted from the pelvic bone. Potential risks of the procedure include pain and soreness and, more rarely, bleeding and infection.busulfan - injection, Busulfex
busulfan - oral, Myleran
Cancer
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.Leukemia
Leukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly speaking, leukemia should refer only to cancer of the white blood cells (the leukocytes) but in practice, it can apply to malignancy of any cellular element in the blood or bone marrow, as in red cell leukemia (erythroleukemia).Mantle Cell Lymphoma (MCL)
Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin's lymphoma. It is not known what causes MCL. MCL signs and symptoms include fever, enlarged spleen and liver, fatigue, and weight loss. Treatment of MCL incorporates radiotherapy and chemotherapy. MCL has a poor prognosis as it typically is diagnosed in a late stage.Multiple Myeloma
Multiple myeloma is a form of cancer that develops in plasma cells, the white blood cells that make antibodies. Symptoms include bone pain, weakness, extreme thirst, nausea, frequent urination, and broken bones. Treatment of multiple myeloma depends upon the staging and symptoms of the disease.mycophenolate
Mycophenolate is an immunosuppressant medication used to prevent rejection of transplant organs (heart, kidney, and liver). Common side effects of mycophenolate include high or low blood pressure (hypertension or hypotension), exacerbation of hypertension, rapid heart rate (tachycardia), swelling (edema), lower extremity edema, peripheral edema, blood clot formation (thrombosis), inflammation of the vein (phlebitis), high blood sugar (hyperglycemia), diabetes mellitus, high cholesterol level in the blood (hypercholesterolemia), high level of blood fats (hyperlipidemia), high uric acid level in the blood (hyperuricemia), high or low blood potassium levels (hyperkalemia/hypokalemia), and others. Mycophenolate can cause fetal harm and should not be used in pregnant women. Do not use if breastfeeding.platelets
Platelets, also known as thrombocytes, are one of the components of blood, along with red blood cells, white blood cells, and plasma, the fluid component. Platelets collected from donors are administered as intravenous transfusions to treat thrombocytopenia, a condition with an abnormally low count of platelets. Common side effects of platelets include transfusion-transmitted infections and septic reactions, production of antibodies against donor platelets (alloimmunization), hemolytic transfusion reactions that destroy red blood cells, feverish (febrile) non-hemolytic reactions, transfusion related acute lung injury (TRALI), transfusion-associated graft-versus-host disease (TA-GVHD), transfusion-associated circulatory overload (TACO), and allergic reactions. Consult your doctor if pregnant or breastfeeding.ruxolitinib
Ruxolitinib is a Janus kinase (JAK) inhibitor used in the treatment of myelofibrosis, a bone marrow cancer, polycythemia vera, a type of blood cancer, and graft-versus-host-disease (GVHD), a complication that can occur after stem cell transplant. Ruxolitinib blocks the activity of Janus kinase enzymes and their signaling pathways and inhibits the development and proliferation of blood cells and immune cells. Common side effects of ruxolitinib include low red blood cell count (anemia), low platelet count (thrombocytopenia), low neutrophil immune cell count (neutropenia), high blood cholesterol levels (hypercholesterolemia), high triglycerides in blood (hypertriglyceridemia), elevation of liver enzyme aspartate aminotransferase (AST), elevation of liver enzyme alanine aminotransferase (ALT), and others.Stem Cells
Stem cell therapy can be used in cancer treatment, bone marrow transplantation, and spinal cord injury. Learn more about stem cell transplants and other uses.Lupus (Systemic Lupus Erythematosus or SLE)
Lupus is a condition characterized by chronic inflammation of body tissues caused by autoimmune disease. Lupus can cause disease of the skin, heart, lungs, kidneys, joints, and nervous system. When internal organs are involved, the condition is called systemic lupus erythematosus (SLE). When only the skin is involved, the condition is called discoid lupus.